Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATP1A1 | P05023 | 12/20 | 0.60 |
| ▸ | ATP1B1 | P05026 | 12/20 | 0.60 |
| ▸ | ATP1A3 | P13637 | 12/20 | 0.60 |
| ▸ | ATP1B2 | P14415 | 12/20 | 0.60 |
| ▸ | ATP1A2 | P50993 | 12/20 | 0.60 |
| ▸ | ATP1B3 | P54709 | 12/20 | 0.60 |
| ▸ | FXYD2 | P54710 | 12/20 | 0.60 |
| ▸ | ATP1A4 | Q13733 | 12/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.60 |
| ▸ | CYP3A5 | P20815 | 2/20 | 0.60 |
| ▸ | AR | P10275 | 1/20 | 0.60 |
| ▸ | ZFP91 | Q96JP5 | 1/20 | 0.60 |
| ▸ | CYP3A7 | P24462 | 1/20 | 0.54 |
| ▸ | STAT3 | P40763 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 3/20 | 0.39 |
| ▸ | RAB9A | P51151 | 3/20 | 0.39 |
| ▸ | PAX8 | Q06710 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | TP53 | P04637 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12360798 | 1.00 | ATP1A1 (0.60) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 | |
| SCHEMBL2256162 | 0.94 | ATP1A1 (0.61) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 | |
| SCHEMBL2256169 | 0.94 | ATP1A1 (0.61) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 | |
| SCHEMBL11893816 | 0.89 | ATP1A1 (0.45) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 | |
| SCHEMBL12360802 | 0.89 | ATP1A1 (0.63) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 | |
| SCHEMBL256803 | 0.88 | ATP1A1 (0.59) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 | |
| SCHEMBL174232 | 0.88 | ATP1A1 (0.59) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 | |
| SCHEMBL19415246 | 0.88 | ATP1A1 (0.59) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 | |
| SCHEMBL15605720 | 0.88 | ATP1A1 (0.60) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 | |
| SCHEMBL20458647 | 0.88 | ATP1A1 (0.60) | ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240115585-A1 | METHODS OF TREATING CANCER | NEUPHARMA, INC. | 2024-04-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240115585-A1 | METHODS OF TREATING CANCER | TP53, DDX21, BRCA1 | ATP1A1 884/4885ATP1B1 716/4885ATP1A3 1482/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.